Table 2 Laboratory characteristics on admission
Proportion | Case fatality | Unadjusted odds ratios (95%CI) for case fatality | P values | |
|---|---|---|---|---|
Neutropenia (< 1500 cell/mm3) (%) | 28/388 (7.2%) | 22 (78.6%) | 11.682 (4.588–29.746) | < 0.001 |
Hemoglobin< 80 g/L | 31/389 (8.0%) | 11 (35.5%) | 1.459 (0.675–3.156) | 0.337 |
RIFLE criteria | ||||
No renal dysfunction | 283/386 (73.3%) | 56 (19.8%) | 1 | |
RIFLE-risk | 50/386 (13.0%) | 16 (32.0%) | 1.908 (0.984–3.699) | 0.056 |
RIFLE-failure | 52/386 (13.5%) | 35 (67.3%) | 8.346 (4.361–15.971) | < 0.001 |
Hypoalbuminemia (albumin ≤30 g/L) | 72/245 (29.4%) | 39 (54.2%) | 3.263 (1.839–5.789) | < 0.001 |
Aspartate Aminotransferase (AST) ≥ 2 ULN | 153/379 (40.4%) | 65 (42.5%) | 3.435 (2.150–5.487) | < 0.001 |
Alanine aminotransferase (ALT) ≥ 2 ULN | 109/378 (28.8%) | 45 (41.3%) | 2.449 (1.520–3.947) | < 0.001 |
Platelet < 100 × 103/mm3 | 169/389 (43.4%) | 70 (41.4%) | 3.282 (2.068–5.208) | < 0.001 |
Procalcitonin | ||||
PCT ≤ 0.005 ng/mL (%) | 6/239 (2.5%) | 2 (33.3%) | 1 | |
PCT > 0.005–2 ng/mL (%) | 83/239 (34.7%) | 11 (13.3%) | 0.306 (0.050–1.871) | 0.2 |
PCT > 2–10 ng/mL (%) | 59/239 (24.7%) | 20 (33.9%) | 1.026 (0.173–6.087) | 0.978 |
PCT > 10–100 ng/mL (%) | 69/239 (28.9%) | 29 (42.0%) | 1.45 (0.249–8.457) | 0.68 |
PCT > 100 ng/mL (%) | 22/239 (9.2%) | 14 (63.6%) | 3.5 (0.520–23.559) | 0.198 |
C-reactive protein (CRP) (median, IQR) (mg/L) | ||||
CRP less than 5 mg/L (%) | 14/341 (4.1%) | 4 (28.6%) | 1 | |
CRP from 5.01 to 20 mg/L (%) | 26/341 (7.6%) | 4 (15.4%) | 0.455 (0.094–2.195) | 0.326 |
CRP from 20.001 to 100 mg/L (%) | 112/341 (32.8%) | 29 (25.9%) | 0.873 (0.254–3.001) | 0.83 |
CRP more than 100 mg/L (%) | 189/341 (55.4%) | 56 (29.6%) | 1.053 (0.317–3.498) | 0.933 |